LABORATORY RESEARCH Antiangiogenic Agents Increase Breast Cancer Stem Cells via the Generation of Tumor Hypoxia Researchers demonstrate that by generating intratumoral hypoxia in human breast cancer xenografts, the antiangiogenic agents sunitinib and bevacizumab increase the population of cancer stem cells. [Proc Natl Acad Sci USA] Abstract Nuclear Receptors Agonists Exert Opposing Effects on the Inflammation Dependent Survival of Breast Cancer Stem Cells Researchers’ data reveal that nuclear receptors agonists (6-OH-11-O-hydroxyphenanthrene, retinoic acid, pioglitazone) reduce the inflammation dependent survival of breast cancer stem cells and that peroxisome proliferator-activated receptor α agonist Wy14643 exerts opposite effects on this phenotype. [Cell Death Differ] Abstract RASSF1A Inhibits Estrogen Receptor α Expression and Estrogen-Independent Signaling: Implications for Breast Cancer Development Here, researchers show that Ras association domain family 1 isoform A (RASSF1A) inhibits breast cancer growth in vivo, and suppresses estrogen receptor a expression and function. [Oncogene] Abstract Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-Positive Breast Cancer Cells Researchers used dual luciferase imaging to investigate CXCR7-dependent scavenging of CXCL12 in breast tumors in vivo and quantify effects of CXCR7 on tumor growth and metastasis of a separate population of CXCR4+ breast cancer cells. [Oncogene] Abstract Regulation of IMP3 by Epidermal Growth Factor Receptor Signaling and Repression by Estrogen Receptor ß: Implications for Triple-Negative Breast Cancer In this study, researchers addressed the hypothesis that signaling pathways, which are characteristic of triple-negative breast carcinomas (TNBCs), impact the expression of insulin-like growth factor II (IGF-II) mRNA-binding protein 3 (IMP3) and that IMP3 contributes to the function of TNBCs. [Oncogene] Abstract Tyrosine Phosphorylation of Estradiol Receptor by Src Regulates Its Hormone-Dependent Nuclear Export and Cell Cycle Progression in Breast Cancer Cells Researchers report that in breast cancer cells, tyrosine phosphorylation of the estradiol receptor α by Src regulates cytoplasmic localization of the receptor and DNA synthesis. [Oncogene] Abstract Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad Epidermal growth factor receptor (EGFR) ligand expression was profiled in bone metastatic MDA-MB-231 cells, and agonist-induced signaling was examined in both breast cancer and osteoblast-like cells. [PLoS One] Abstract Estrogen Receptor-α 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells Here, researchers investigated the molecular mechanisms underlying the antiestrogen signaling in estrogen receptor (ER)-negative breast cancer MDA-MB-231 and MDA-MB-436 cells that express high levels of endogenous ER-α36. [PLoS One] Abstract The Cyclin-Like Protein Spy1/RINGO Promotes Mammary Transformation and Is Elevated in Human Breast Cancer Researchers show for the first time that enhanced levels of Spy1 protein are found in a large number of human breast cancers and that knockdown of Spy1 impairs breast cancer cell proliferation. [BMC Cancer] Abstract CLINICAL RESEARCH PI3K/AKT/mTOR Inhibitors in Patients with Breast and Gynecologic Malignancies Harboring PIK3CA Mutations Tumors from patients with breast, cervical, endometrial, and ovarian cancer referred to the Clinical Center for Targeted Therapy were analyzed for PIK3CA, KRAS, NRAS, and BRAF mutations. Patients with PIK3CA mutations were treated, whenever feasible, with agents targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. [J Clin Oncol] Abstract Molecular Alterations between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor Metastatic breast cancers have historically been presumed to have the same predictive biomarkers as the initial primary tumor. Researchers compared the expression of these biomarkers in a large paired tissue microarray series of primary and subsequent relapsed tumors. [Oncologist] Abstract |